Cargando…
Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries
ABSTRACT: The global spread of COVID-19 has raised the importance of pharmaceutical drug development as intractable and hot research. Developing new drug molecules to overcome any disease is a costly and lengthy process, but the process continues uninterrupted. The critical point to consider the dru...
Autores principales: | Selvaraj, Chandrabose, Chandra, Ishwar, Singh, Sanjeev Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536481/ https://www.ncbi.nlm.nih.gov/pubmed/34686947 http://dx.doi.org/10.1007/s11030-021-10326-z |
Ejemplares similares
-
Application of Artificial Intelligence-Based Technologies in the Healthcare Industry: Opportunities and Challenges
por: Lee, DonHee, et al.
Publicado: (2021) -
Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance
por: Kassekert, Raymond, et al.
Publicado: (2022) -
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review
por: Kolluri, Sheela, et al.
Publicado: (2022) -
Opportunities and challenges in application of artificial intelligence in pharmacology
por: Kumar, Mandeep, et al.
Publicado: (2023) -
Artificial intelligence and machine learning in healthcare: Scope and opportunities to use ChatGPT
por: Singh, Ajai, et al.
Publicado: (2023)